Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Sandu Pharmaceuticals Ltd

Your Vote -

Buy

33.33%

Hold

33.33%

Sell

33.33%

33.33%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Sandu Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Sandu Pharmaceut - Announcement Under Regulation 30-Update-Newspaper Publication Informing About The 100 Days' Campaign - \

    20 Aug 2025, 12:43PM Newspaper Publication informing 100 days campaign saksham niveshak launched by IEPF
  • Sandu Pharmaceut - Announcement Under Regulation 30-Update-Newspaper Publication Informing About The 100 Days' Campaign - \

    20 Aug 2025, 12:43PM Newspaper Publication informing 100 days campaign saksham niveshak launched by IEPF
  • Sandu Pharmaceut has declared 8% Final dividend for the financial year March 2025

    16 Aug 2025, 7:00AM Sandu Pharmaceuticals Ltd. on Wednesday, 28 May 2025, has announced Final dividend of 8 percent on Equity Share, to its shareholders holding shares on
  • Sandu Pharmaceut - Announcement Under Regulation 30-Update-Intimation Of The Conclusion Of Proceeding In Respect Of The Show

    14 Aug 2025, 11:03PM Intimation under regulation 30
  • Sandu Pharmaceut Q1 net profit up 29.41% at Rs 0.22 cr

    13 Aug 2025, 8:50PM The company reported standalone net profit of Rs 0.22 crore for the quarter ended June 30, 2025 as compared to Rs 0.17 crore in the same period last y
  • Sandu Pharmaceut - Intimation About The Record Date

    13 Aug 2025, 6:16PM Intimation about the Record date
  • Sandu Pharmaceut - Intimation About The Book Closure For The 40Th Annual General Meeting

    13 Aug 2025, 6:14PM Intimation about the Book Closure for the 40th Annual General Meeting
  • Sandu Pharmaceut - Disclosure Under Regulation 30

    13 Aug 2025, 6:12PM Regulation 30 dislosure
  • Sandu Pharmaceut - Intimation About The Date Of The 40Th Annual General Meeting

    13 Aug 2025, 6:10PM Intimation about 40th Annual general Meeting
  • Sandu Pharmaceut - Complaince Under Reg 32(1)(3) -Statement Of Deviation And Variation Of Funds For Q Ended 30Th June 2025

    13 Aug 2025, 6:08PM statement of devaition or variation of funds for q ended 30th June 2025
  • Sandu Pharmaceut - Unaudited Financials For The Q Ended 30Th June 2025

    13 Aug 2025, 5:56PM Unaudited Financials for the Q ended 30th June 2025
  • Sandu Pharmaceut - Board Meeting Outcome for Outcome Of The Board Meeting Dated 13Th August 2025

    13 Aug 2025, 5:51PM Outcome of the Board Meeting dated 13th August 2025
  • Sandu Pharmaceut - Announcement Under Regulation 30-Update-Intimation In Respect Of The Refund Order Received From Departmen

    11 Aug 2025, 12:23PM Announcement under Regulation 30 on intimation on refund order received from Department of Commercial Taxes, Government of Goa
  • Sandu Pharmaceut - Board Meeting Intimation for Approval Of Unaudited Financial Results For Q Ended 30Th June 2025

    4 Aug 2025, 3:54PM Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to conside
  • Sandu Pharmaceut has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    19 Jul 2025, 10:50AM As of June 2025, 42.91% is owned by Indian Promoters and 57.10% by Public. <p align=justify> Top five Promoters holding highest number of shares of Sa
  • Sandu Pharmaceut - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Jul 2025, 2:59PM Complaince Certificate under Reg 74(5) of SEBI(DP) Regulation for the Q ended 30th June 2025

Key fundamentals

Evaluate the intrinsic value of Sandu Pharmaceuticals Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 42.0754 40.5953 39.2444 36.4746 33.5104
Liabilities 42.0754 40.5953 39.2444 36.4746 33.5104
Equity 9.661 9.661 9.661 8.8107 7.9209
Gross Profit 2.7622 2.2973 2.4893 2.874 2.159
Net Profit 1.5489 1.4606 1.5239 1.5893 1.0924
Cash From Operating Activities 0.9504 0.7614 0.2212 0.9487 7.59
NPM(%) 2.3 2.17 2.33 2.42 1.85
Revenue 67.1924 67.2807 65.349 65.5005 58.7554
Expenses 64.4302 64.9834 62.8597 62.6265 56.5963
ROE(%) 3.79 3.57 3.73 3.89 2.67

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Sandu Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 809.50 0.68 73.44 27.18 301.39 0.62
Lotus Eye Hospital and Institute Ltd 118.70 -4.24 393.23 99.05 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 22.11 1.89 0.00 205.67 -39.50 0.00
Astec Lifesciences Ltd 860.80 0.98 0.00 93.41 -604.77 0.00

Company Info

The name "Sandu" leads in this roll call of honour. 10th May 1899 was the day Sandu Brothers chose to revolutionise the manufacture of Ayurvedic medicines. Commitment to the spread of Ayurveda and bringing health even to the poor were the lofty ideals that have been the foundation of the success of Sandu. High quality made Sandu medicines popular. Started on 10th May 1899 at Thakurdwar, Mumbai, the factory was later shifted to Chembur to cater to growing demand. Sandu is now a name established throughout India and has earned acceptance even beyond its borders and not in the Indian diaspora alone. Over 120 years, the secret of Sandu's success lies in our commitment to quality and firm adherence to the basic tenets of Ayurveda. Today, the fourth generation of Sandu at the helm implements a seamless confluence between tradition and modern pharmaceutical practices. We are growing, but without compromising on the quality in any way.Sandu is a benchmark of Quality amongst doctors, practitioners, and common people alike. Our commitment to quality is reflected in the ISO 9001:2000 certification we have earned for our Group operations which include our manufacturing units at New Mumbai and Goa as well as our full-fledged research unit - Sandu Research Foundation Pvt Ltd. While we rigorously follow traditional formulations, our manufacturing processes are totally aseptic and state-of-the-art with no human contact during the manufacturing process. Today, when allopathic medicines dominate the market, Sandu takes deserved pride in being known as the manufacturer of Ayurvedic Medicines with Visible Efficacy.

The name "Sandu" leads in this roll call of honour. 10th May 1899 was the day Sandu Brothers chose to revolutionise the manufacture of Ayurvedic medicines. Commitment to the spread of Ayurveda and bringing health even to the poor were the lofty ideals that have been the foundation of the success of Sandu. High quality made Sandu medicines popular. Started on 10th May 1899 at Thakurdwar, Mumbai, the factory was later shifted to Chembur to cater to growing demand. Sandu is now a name established throughout India and has earned acceptance even beyond its borders and not in the Indian diaspora alone. Over 120 years, the secret of Sandu's success lies in our commitment to quality and firm adherence to the basic tenets of Ayurveda. Today, the fourth generation of Sandu at the helm implements a seamless confluence between tradition and modern pharmaceutical practices. We are growing, but without compromising on the quality in any way.Sandu is a benchmark of Quality amongst doctors, practitioners, and common people alike. Our commitment to quality is reflected in the ISO 9001:2000 certification we have earned for our Group operations which include our manufacturing units at New Mumbai and Goa as well as our full-fledged research unit - Sandu Research Foundation Pvt Ltd. While we rigorously follow traditional formulations, our manufacturing processes are totally aseptic and state-of-the-art with no human contact during the manufacturing process. Today, when allopathic medicines dominate the market, Sandu takes deserved pride in being known as the manufacturer of Ayurvedic Medicines with Visible Efficacy.

Read More

Parent Organisation

Sandu Pharmaceuticals Ltd.

Founded

15/11/1985

Managing Director

NSE Symbol

FAQ

The current price of Sandu Pharmaceuticals Ltd is

The 52-week high for Sandu Pharmaceuticals Ltd is

The market capitalization of Sandu Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Sandu Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Sandu Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Sandu Pharmaceuticals Ltd shares.

The CEO of Sandu Pharmaceuticals Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT